Venus Concept Inc. (VERO)
2.85
-0.50 (-14.93%)
At close: Apr 17, 2025, 3:59 PM
2.95
3.68%
After-hours: Apr 17, 2025, 07:58 PM EDT
-14.93% (1D)
| Bid | 2.88 |
| Market Cap | 2.96M |
| Revenue (ttm) | 54.87M |
| Net Income (ttm) | -39.1M |
| EPS (ttm) | -71.21 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | -0.28 |
| Analyst | n/a |
| Ask | 3.03 |
| Volume | 213,592 |
| Avg. Volume (20D) | 1,200,991 |
| Open | 3.29 |
| Previous Close | 3.35 |
| Day's Range | 2.82 - 3.54 |
| 52-Week Range | 2.16 - 17.49 |
| Beta | 0.26 |
About VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application devi...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 12, 2017
Employees 292
Stock Exchange NASDAQ
Ticker Symbol VERO
Website https://www.venusconcept.com
Next Earnings Release
Venus Concept Inc. is scheduled to release its earnings on May 15, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
-12.99%
Venus Concept shares are trading higher. The compa...
Unlock content with
Pro Subscription
1 week ago
+205.82%
Venus Concept shares are trading higher after the company announced it secured $23.24 million in bridge financing from Madryn Health Partners.
2 weeks ago · seekingalpha.com
Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call TranscriptVenus Concept Inc. (NASDAQ:VERO ) Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - EVP and CFO Conference Call Participants Ma...